Skip to Content

ACAM2000 Approval History

  • FDA approved: Yes (First approved August 31st, 2007)
  • Brand name: ACAM2000
  • Generic name: Smallpox (Vaccinia) Vaccine, Live
  • Company: Acambis Inc.
  • Treatment for: Smallpox Prophylaxis

ACAM2000 is live vaccinia virus smallpox vaccine intended for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. ACAM2000 is the first biodefense vaccine to be approved as part of the US response to the 2001 bioterrorism attacks.

Development History and FDA Approval Process for ACAM2000

Sep  4, 2007Approval FDA Approves ACAM2000 Vaccine for Protection Against Smallpox

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.